Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model

scientific article

Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.42.7.1831
P932PMC publication ID105691
P698PubMed publication ID9661029

P2093author name stringA Schürmann
G Schlüter
G Schmuck
P2860cites workElectrical activities in thin sections from the mammalian brain maintained in chemically-defined media in vitro.Q51225549
Glycine-induced CA1 excitotoxicity in the rat hippocampal slice.Q51619931
In vitro and in vivo characterization of the NMDA receptor-linked strychnine-insensitive glycine siteQ67521485
Glycine reverses 7-Cl kynurenate blockade of glutamate neurotoxicity in cell cultureQ69353820
Attenuated inhibition by levofloxacin, l-isomer of ofloxacin, on GABA response in the dissociated rat hippocampal neuronsQ71525856
Central nervous system toxicity of quinolones: human and animal findingsQ28329722
The proconvulsive activity of quinolone antibiotics in an animal modelQ28333203
Magnesium gates glutamate-activated channels in mouse central neuronesQ29616237
Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sitesQ35354313
Gating of GABAergic Inhibition in Hippocampal Pyramidal CellsQ36515579
Impact of chemical structure on quinolone potency, spectrum and side effectsQ36942967
Competitive antagonism of glycine at the N-methyl-d-aspartate (NMDA) receptorQ37076226
Drug interactions with quinolones.Q38364042
In vitro modulation of hippocampal pyramidal cell response by quinolones: effects of HA 966 and gamma-hydroxybutyric acid.Q39783134
Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranesQ39817630
Hippocampal activity in the presence of quinolones and fenbufen in vitroQ40284282
Antagonism of GABAA receptors by 4-quinolonesQ40855311
The effects of quinolones and NSAIDs upon GABA-evoked currents recorded from rat dorsal root ganglion neuronesQ41129678
Neurochemical studies on quinolone antibiotics: effects on glutamate, GABA and adenosine systems in mammalian CNS.Q42199003
Effects of some quinolones on imipenem-induced seizures in DBA/2 miceQ42283463
Quinolones do not interact with NMDA receptor in dissociated rat hippocampal neurons.Q48637807
Interaction of various non-steroidal anti-inflammatories and quinolone antimicrobials on GABA response in rat dissociated hippocampal pyramidal neuronsQ48638164
Quinolones and fenbufen interact with GABAA receptor in dissociated hippocampal cells of ratQ48683939
P433issue7
P407language of work or nameEnglishQ1860
P304page(s)1831-1836
P577publication date1998-07-01
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titleDetermination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model
P478volume42

Reverse relations

cites work (P2860)
Q42922049A seizure attributed to ofloxacine in a woman undergoing detoxification for alcohol dependence
Q36862757Association between oral fluoroquinolones and seizures: A self-controlled case series study
Q44019765Clinical toxicological aspects of fluoroquinolones
Q37003271Clonic Seizures in GAERS Rats after Oral Administration of Enrofloxacin
Q28146268Comparative tolerability of the newer fluoroquinolone antibacterials
Q43294249Convulsant activity and pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of gemifloxacin in rats
Q28066841Dysregulated mitochondrial and chloroplast bioenergetics from a translational medical perspective (Review)
Q44525399Evaluation of the possible epileptogenic activity of ciprofloxacin: the role of Nigella sativa on amino acids neurotransmitters
Q34958317Fluoroquinolones for the treatment of outpatient community-acquired pneumonia
Q35086805Fluoroquinolones in the elderly: safety considerations
Q36047066Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy
Q33588540Moxifloxacin
Q35846371Moxifloxacin Induced Seizures -A Case Report
Q28373212Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections
Q39471040Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of fluoroquinolones in rats
Q48121689Pharmacological validation of a semi-automated in vitro hippocampal brain slice assay for assessment of seizure liability
Q33717059Potential interactions of the extended-spectrum fluoroquinolones with the CNS.
Q40782394Quinolone antibiotics and suicidal behavior: analysis of the World Health Organization's adverse drug reactions database and discussion of potential mechanisms
Q35074608Quinolones in dermatology
Q46971476Retinal safety of a new fluoroquinolone, pradofloxacin, in cats: assessment with electroretinography
Q34617485Safety considerations of fluoroquinolones in the elderly: an update
Q34110521Safety profile of the fluoroquinolones: focus on levofloxacin
Q28243911Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes
Q37586997Seizures associated with levofloxacin: case presentation and literature review
Q42951097The Effect of Ciprofloxacin Injection on Genetically Absence Prone (Wag/Rij) Rat's Electroencephalogram Characteristics.
Q30311089The efficacy of trovafloxacin versus ceftriaxone in the treatment of experimental brain abscess/cerebritis in the rat.
Q33770084Toxicity of quinolones

Search more.